Global Glucagon Market Size, Manufacturers, Opportunities and Forecast to 2030
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
According to APO Research, The global Glucagon market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon.
The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Glucagon market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon.
The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
- Taj Pharmaceuticals
- Xeris Pharmaceuticals
- Inject Glucagon
- Nasal Glucagon
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Glucagon Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Glucagon Sales Estimates and Forecasts (2019-2030)
1.3 Glucagon Market by Type
1.3.1 Inject Glucagon
1.3.2 Nasal Glucagon
1.4 Global Glucagon Market Size by Type
1.4.1 Global Glucagon Market Size Overview by Type (2019-2030)
1.4.2 Global Glucagon Historic Market Size Review by Type (2019-2024)
1.4.3 Global Glucagon Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Glucagon Sales Breakdown by Type (2019-2024)
1.5.2 Europe Glucagon Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Glucagon Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Glucagon Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Glucagon Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Glucagon Industry Trends
2.2 Glucagon Industry Drivers
2.3 Glucagon Industry Opportunities and Challenges
2.4 Glucagon Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Glucagon Revenue (2019-2024)
3.2 Global Top Players by Glucagon Sales (2019-2024)
3.3 Global Top Players by Glucagon Price (2019-2024)
3.4 Global Glucagon Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Glucagon Key Company Manufacturing Sites & Headquarters
3.6 Global Glucagon Company, Product Type & Application
3.7 Global Glucagon Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Glucagon Market CR5 and HHI
3.8.2 Global Top 5 and 10 Glucagon Players Market Share by Revenue in 2023
3.8.3 2023 Glucagon Tier 1, Tier 2, and Tier
4 GLUCAGON REGIONAL STATUS AND OUTLOOK
4.1 Global Glucagon Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Glucagon Historic Market Size by Region
4.2.1 Global Glucagon Sales in Volume by Region (2019-2024)
4.2.2 Global Glucagon Sales in Value by Region (2019-2024)
4.2.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Glucagon Forecasted Market Size by Region
4.3.1 Global Glucagon Sales in Volume by Region (2025-2030)
4.3.2 Global Glucagon Sales in Value by Region (2025-2030)
4.3.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 GLUCAGON BY APPLICATION
5.1 Glucagon Market by Application
5.1.1 Emergency Kits
5.1.2 General Use
5.1.3 Diagnostic & Motility
5.1.4 Cardiogenic Shock
5.1.5 Others
5.2 Global Glucagon Market Size by Application
5.2.1 Global Glucagon Market Size Overview by Application (2019-2030)
5.2.2 Global Glucagon Historic Market Size Review by Application (2019-2024)
5.2.3 Global Glucagon Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Glucagon Sales Breakdown by Application (2019-2024)
5.3.2 Europe Glucagon Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Glucagon Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Glucagon Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Glucagon Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Novo Nordisk Comapny Information
6.1.2 Novo Nordisk Business Overview
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Glucagon Product Portfolio
6.1.5 Novo Nordisk Recent Developments
6.2 Eli Lilly
6.2.1 Eli Lilly Comapny Information
6.2.2 Eli Lilly Business Overview
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Glucagon Product Portfolio
6.2.5 Eli Lilly Recent Developments
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Comapny Information
6.3.2 Fresenius Kabi Business Overview
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Glucagon Product Portfolio
6.3.5 Fresenius Kabi Recent Developments
6.4 Torrent Labs
6.4.1 Torrent Labs Comapny Information
6.4.2 Torrent Labs Business Overview
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Torrent Labs Glucagon Product Portfolio
6.4.5 Torrent Labs Recent Developments
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Comapny Information
6.5.2 Taj Pharmaceuticals Business Overview
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
6.5.5 Taj Pharmaceuticals Recent Developments
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Comapny Information
6.6.2 Xeris Pharmaceuticals Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Glucagon Sales by Country
7.1.1 North America Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Glucagon Sales by Country (2019-2024)
7.1.3 North America Glucagon Sales Forecast by Country (2025-2030)
7.2 North America Glucagon Market Size by Country
7.2.1 North America Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Glucagon Market Size by Country (2019-2024)
7.2.3 North America Glucagon Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Glucagon Sales by Country
8.1.1 Europe Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Glucagon Sales by Country (2019-2024)
8.1.3 Europe Glucagon Sales Forecast by Country (2025-2030)
8.2 Europe Glucagon Market Size by Country
8.2.1 Europe Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Glucagon Market Size by Country (2019-2024)
8.2.3 Europe Glucagon Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Glucagon Sales by Country
9.1.1 Asia-Pacific Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Glucagon Sales by Country (2019-2024)
9.1.3 Asia-Pacific Glucagon Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Glucagon Market Size by Country
9.2.1 Asia-Pacific Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Glucagon Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Glucagon Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Glucagon Sales by Country
10.1.1 Latin America Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Glucagon Sales by Country (2019-2024)
10.1.3 Latin America Glucagon Sales Forecast by Country (2025-2030)
10.2 Latin America Glucagon Market Size by Country
10.2.1 Latin America Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Glucagon Market Size by Country (2019-2024)
10.2.3 Latin America Glucagon Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Glucagon Sales by Country
11.1.1 Middle East and Africa Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Glucagon Sales by Country (2019-2024)
11.1.3 Middle East and Africa Glucagon Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Glucagon Market Size by Country
11.2.1 Middle East and Africa Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Glucagon Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Glucagon Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Glucagon Value Chain Analysis
12.1.1 Glucagon Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Glucagon Production Mode & Process
12.2 Glucagon Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Glucagon Distributors
12.2.3 Glucagon Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Glucagon Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Glucagon Sales Estimates and Forecasts (2019-2030)
1.3 Glucagon Market by Type
1.3.1 Inject Glucagon
1.3.2 Nasal Glucagon
1.4 Global Glucagon Market Size by Type
1.4.1 Global Glucagon Market Size Overview by Type (2019-2030)
1.4.2 Global Glucagon Historic Market Size Review by Type (2019-2024)
1.4.3 Global Glucagon Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Glucagon Sales Breakdown by Type (2019-2024)
1.5.2 Europe Glucagon Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Glucagon Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Glucagon Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Glucagon Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Glucagon Industry Trends
2.2 Glucagon Industry Drivers
2.3 Glucagon Industry Opportunities and Challenges
2.4 Glucagon Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Glucagon Revenue (2019-2024)
3.2 Global Top Players by Glucagon Sales (2019-2024)
3.3 Global Top Players by Glucagon Price (2019-2024)
3.4 Global Glucagon Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Glucagon Key Company Manufacturing Sites & Headquarters
3.6 Global Glucagon Company, Product Type & Application
3.7 Global Glucagon Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Glucagon Market CR5 and HHI
3.8.2 Global Top 5 and 10 Glucagon Players Market Share by Revenue in 2023
3.8.3 2023 Glucagon Tier 1, Tier 2, and Tier
4 GLUCAGON REGIONAL STATUS AND OUTLOOK
4.1 Global Glucagon Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Glucagon Historic Market Size by Region
4.2.1 Global Glucagon Sales in Volume by Region (2019-2024)
4.2.2 Global Glucagon Sales in Value by Region (2019-2024)
4.2.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Glucagon Forecasted Market Size by Region
4.3.1 Global Glucagon Sales in Volume by Region (2025-2030)
4.3.2 Global Glucagon Sales in Value by Region (2025-2030)
4.3.3 Global Glucagon Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 GLUCAGON BY APPLICATION
5.1 Glucagon Market by Application
5.1.1 Emergency Kits
5.1.2 General Use
5.1.3 Diagnostic & Motility
5.1.4 Cardiogenic Shock
5.1.5 Others
5.2 Global Glucagon Market Size by Application
5.2.1 Global Glucagon Market Size Overview by Application (2019-2030)
5.2.2 Global Glucagon Historic Market Size Review by Application (2019-2024)
5.2.3 Global Glucagon Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Glucagon Sales Breakdown by Application (2019-2024)
5.3.2 Europe Glucagon Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Glucagon Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Glucagon Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Glucagon Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Novo Nordisk Comapny Information
6.1.2 Novo Nordisk Business Overview
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Glucagon Product Portfolio
6.1.5 Novo Nordisk Recent Developments
6.2 Eli Lilly
6.2.1 Eli Lilly Comapny Information
6.2.2 Eli Lilly Business Overview
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Glucagon Product Portfolio
6.2.5 Eli Lilly Recent Developments
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Comapny Information
6.3.2 Fresenius Kabi Business Overview
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Glucagon Product Portfolio
6.3.5 Fresenius Kabi Recent Developments
6.4 Torrent Labs
6.4.1 Torrent Labs Comapny Information
6.4.2 Torrent Labs Business Overview
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Torrent Labs Glucagon Product Portfolio
6.4.5 Torrent Labs Recent Developments
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Comapny Information
6.5.2 Taj Pharmaceuticals Business Overview
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
6.5.5 Taj Pharmaceuticals Recent Developments
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Comapny Information
6.6.2 Xeris Pharmaceuticals Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Glucagon Sales by Country
7.1.1 North America Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Glucagon Sales by Country (2019-2024)
7.1.3 North America Glucagon Sales Forecast by Country (2025-2030)
7.2 North America Glucagon Market Size by Country
7.2.1 North America Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Glucagon Market Size by Country (2019-2024)
7.2.3 North America Glucagon Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Glucagon Sales by Country
8.1.1 Europe Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Glucagon Sales by Country (2019-2024)
8.1.3 Europe Glucagon Sales Forecast by Country (2025-2030)
8.2 Europe Glucagon Market Size by Country
8.2.1 Europe Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Glucagon Market Size by Country (2019-2024)
8.2.3 Europe Glucagon Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Glucagon Sales by Country
9.1.1 Asia-Pacific Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Glucagon Sales by Country (2019-2024)
9.1.3 Asia-Pacific Glucagon Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Glucagon Market Size by Country
9.2.1 Asia-Pacific Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Glucagon Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Glucagon Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Glucagon Sales by Country
10.1.1 Latin America Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Glucagon Sales by Country (2019-2024)
10.1.3 Latin America Glucagon Sales Forecast by Country (2025-2030)
10.2 Latin America Glucagon Market Size by Country
10.2.1 Latin America Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Glucagon Market Size by Country (2019-2024)
10.2.3 Latin America Glucagon Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Glucagon Sales by Country
11.1.1 Middle East and Africa Glucagon Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Glucagon Sales by Country (2019-2024)
11.1.3 Middle East and Africa Glucagon Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Glucagon Market Size by Country
11.2.1 Middle East and Africa Glucagon Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Glucagon Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Glucagon Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Glucagon Value Chain Analysis
12.1.1 Glucagon Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Glucagon Production Mode & Process
12.2 Glucagon Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Glucagon Distributors
12.2.3 Glucagon Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
